Oxford COVID-19 vaccine, Covishield, manufactured by the Serum Institute of India, will be sold to the Indian government at Rs 200 per dose, SII head Adar Poonawalla told India Today. The vaccine will be sold at a higher price of Rs 1,000 per dose to private buyers. The Oxford University-AstraZeneca vaccine was granted emergency authorisation by the Indian regulator on Sunday, on the condition that Serum Institute doesn't export the shots, to ensure the safety of the vulnerable populations in India. Watch the video for more.
Copyright©2021 Living Media India Limited. For reprint rights: Syndications Today